INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Repros Therapeutics Inc. (RPRX) To Contact The Firm

News provided by

Oct 17, 2014, 08:28 ET

NEW YORK, Oct. 17, 2014 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Repros Therapeutics Inc. ("Repros" or the "Company") (NASDAQ: RPRX).

The investigation focuses on whether the Company and its executives violated federal securities laws by making false and misleading statements and/or failing to disclose material facts regarding its business and operations.

On October 17, 2014, Repros announced that it had received a communication from the Food and Drug Administration "indicating that based on its preliminary review of the Company's briefing document, there was not sufficient clinical information provided for the meeting" regarding its new drug Androxal® "to be a Type B Pre-NDA meeting."

Following this news, the price of Repros stock declined by $4.20 per share, or nearly 40%, to close on October 17, 2014 at $6.31 per share.

Request more information now by clicking here: www.faruqilaw.com/RPRX. There is no cost or obligation to you.

Take Action

If you invested in Repros stock or options prior to October 17, 2014 and would like to discuss your legal rights, visit www.faruqilaw.com/RPRX. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Repros' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330

Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO

SOURCE Faruqi & Faruqi, LLP